PEGylated insulin-like growth factor-I affords protection and facilitates recovery of lost functions post-focal ischemia

Abstract Insulin-like growth factor-I (IGF-I) is involved in the maturation and maintenance of neurons, and impaired IGF-I signaling has been shown to play a role in various neurological diseases including stroke. The aim of the present study was to investigate the efficacy of an optimized IGF-I var...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Kim Parker, Antonio Berretta, Stefanie Saenger, Manaswini Sivaramakrishnan, Simon A. Shirley, Friedrich Metzger, Andrew N. Clarkson
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2017
Materias:
R
Q
Acceso en línea:https://doaj.org/article/9573be34d1cf477683505c56800f4a1c
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:9573be34d1cf477683505c56800f4a1c
record_format dspace
spelling oai:doaj.org-article:9573be34d1cf477683505c56800f4a1c2021-12-02T12:30:52ZPEGylated insulin-like growth factor-I affords protection and facilitates recovery of lost functions post-focal ischemia10.1038/s41598-017-00336-z2045-2322https://doaj.org/article/9573be34d1cf477683505c56800f4a1c2017-03-01T00:00:00Zhttps://doi.org/10.1038/s41598-017-00336-zhttps://doaj.org/toc/2045-2322Abstract Insulin-like growth factor-I (IGF-I) is involved in the maturation and maintenance of neurons, and impaired IGF-I signaling has been shown to play a role in various neurological diseases including stroke. The aim of the present study was to investigate the efficacy of an optimized IGF-I variant by adding a 40 kDa polyethylene glycol (PEG) chain to IGF-I to form PEG-IGF-I. We show that PEG-IGF-I has a slower clearance which allows for twice-weekly dosing to maintain steady-state serum levels in mice. Using a photothrombotic model of focal stroke, dosing from 3 hrs post-stroke dose-dependently (0.3–1 mg/kg) decreases the volume of infarction and improves motor behavioural function in both young 3-month and aged 22–24 month old mice. Further, PEG-IGF-I treatment increases GFAP expression when given early (3 hrs post-stroke), increases Synaptophysin expression and increases neurogenesis in young and aged. Finally, neurons (P5–6) cultured in vitro on reactive astrocytes in the presence of PEG-IGF-I showed an increase in neurite length, indicating that PEG-IGF-I can aid in sprouting of new connections. This data suggests a modulatory role of IGF-I in both protective and regenerative processes, and indicates that therapeutic approaches using PEG-IGF-I should be given early and where the endogenous regenerative potential is still high.Kim ParkerAntonio BerrettaStefanie SaengerManaswini SivaramakrishnanSimon A. ShirleyFriedrich MetzgerAndrew N. ClarksonNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 7, Iss 1, Pp 1-15 (2017)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Kim Parker
Antonio Berretta
Stefanie Saenger
Manaswini Sivaramakrishnan
Simon A. Shirley
Friedrich Metzger
Andrew N. Clarkson
PEGylated insulin-like growth factor-I affords protection and facilitates recovery of lost functions post-focal ischemia
description Abstract Insulin-like growth factor-I (IGF-I) is involved in the maturation and maintenance of neurons, and impaired IGF-I signaling has been shown to play a role in various neurological diseases including stroke. The aim of the present study was to investigate the efficacy of an optimized IGF-I variant by adding a 40 kDa polyethylene glycol (PEG) chain to IGF-I to form PEG-IGF-I. We show that PEG-IGF-I has a slower clearance which allows for twice-weekly dosing to maintain steady-state serum levels in mice. Using a photothrombotic model of focal stroke, dosing from 3 hrs post-stroke dose-dependently (0.3–1 mg/kg) decreases the volume of infarction and improves motor behavioural function in both young 3-month and aged 22–24 month old mice. Further, PEG-IGF-I treatment increases GFAP expression when given early (3 hrs post-stroke), increases Synaptophysin expression and increases neurogenesis in young and aged. Finally, neurons (P5–6) cultured in vitro on reactive astrocytes in the presence of PEG-IGF-I showed an increase in neurite length, indicating that PEG-IGF-I can aid in sprouting of new connections. This data suggests a modulatory role of IGF-I in both protective and regenerative processes, and indicates that therapeutic approaches using PEG-IGF-I should be given early and where the endogenous regenerative potential is still high.
format article
author Kim Parker
Antonio Berretta
Stefanie Saenger
Manaswini Sivaramakrishnan
Simon A. Shirley
Friedrich Metzger
Andrew N. Clarkson
author_facet Kim Parker
Antonio Berretta
Stefanie Saenger
Manaswini Sivaramakrishnan
Simon A. Shirley
Friedrich Metzger
Andrew N. Clarkson
author_sort Kim Parker
title PEGylated insulin-like growth factor-I affords protection and facilitates recovery of lost functions post-focal ischemia
title_short PEGylated insulin-like growth factor-I affords protection and facilitates recovery of lost functions post-focal ischemia
title_full PEGylated insulin-like growth factor-I affords protection and facilitates recovery of lost functions post-focal ischemia
title_fullStr PEGylated insulin-like growth factor-I affords protection and facilitates recovery of lost functions post-focal ischemia
title_full_unstemmed PEGylated insulin-like growth factor-I affords protection and facilitates recovery of lost functions post-focal ischemia
title_sort pegylated insulin-like growth factor-i affords protection and facilitates recovery of lost functions post-focal ischemia
publisher Nature Portfolio
publishDate 2017
url https://doaj.org/article/9573be34d1cf477683505c56800f4a1c
work_keys_str_mv AT kimparker pegylatedinsulinlikegrowthfactoriaffordsprotectionandfacilitatesrecoveryoflostfunctionspostfocalischemia
AT antonioberretta pegylatedinsulinlikegrowthfactoriaffordsprotectionandfacilitatesrecoveryoflostfunctionspostfocalischemia
AT stefaniesaenger pegylatedinsulinlikegrowthfactoriaffordsprotectionandfacilitatesrecoveryoflostfunctionspostfocalischemia
AT manaswinisivaramakrishnan pegylatedinsulinlikegrowthfactoriaffordsprotectionandfacilitatesrecoveryoflostfunctionspostfocalischemia
AT simonashirley pegylatedinsulinlikegrowthfactoriaffordsprotectionandfacilitatesrecoveryoflostfunctionspostfocalischemia
AT friedrichmetzger pegylatedinsulinlikegrowthfactoriaffordsprotectionandfacilitatesrecoveryoflostfunctionspostfocalischemia
AT andrewnclarkson pegylatedinsulinlikegrowthfactoriaffordsprotectionandfacilitatesrecoveryoflostfunctionspostfocalischemia
_version_ 1718394293390934016